Q2 2017 Holdings
Filed 2017-08-11 | 7 holdings | $961.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Abbvie Inc(ABBV) | Common | 00287Y109 | $859.6M | 11,854,758 | 89.4% |
| Biogen Inc(BIIB) | Common | 09062X103 | $100.0M | 368,645 | 10.4% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $617.0K | 11,400,424 | 0.1% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $443.4K | 7,647,977 | 0.0% |
| Theravance Biopharma Inc(TBPH) | Common | G8807B106 | $426.5K | 10,706,180 | 0.0% |
| Gilead Sciences Inc(GILD) | Common | 375558103 | $157.1K | 2,220,100 | 0.0% |
| Bioverativ Inc | Common | 09075E100 | $119.0K | 1,977,764 | 0.0% |